Page 161 - 南京医科大学自然版

第46卷第6期 徐玮婧，雷 洋，王朝霞. 糖代谢重编程在肿瘤耐药中的研究进展［J］.
2026年6月 南京医科大学学报（自然科学版），2026，46（6）：935-944 ·943 ·

signaling［J］. Cancer Res，2022，82（5）：831-845 ［40］HOLLOWAY R W，MARIGNANI P A. Targeting mTOR
［28］HOU L，ZHAO Y，SONG G Q，et al. Interfering cellular and glycolysis in HER2⁃positive breast cancer［J］. Can⁃
lactate homeostasis overcomes Taxol resistance of breast cers（Basel），2021，13（12）：2922
cancer cells through the microRNA⁃124⁃mediated lactate ［41］LIU H，LYU H，JIANG G，et al. ALKBH5⁃mediated m6A
transporter（MCT1）inhibition［J］. Cancer Cell Int，2019， demethylation of GLUT4 mRNA promotes glycolysis and
19：193 resistance to HER2⁃targeted therapy in breast cancer［J］.
［29］DONG Q，ZHOU C，REN H，et al. Lactate⁃induced MRP1 Cancer Res，2022，82（21）：3974-3986
expression contributes to metabolism⁃based etoposide re⁃ ［42］LI W，ZHOU C，YU L，et al. Tumor⁃derived lactate pro⁃
sistance in non⁃small cell lung cancer cells［J］. Cell Com⁃ motes resistance to bevacizumab treatment by facilitating
mun Signal，2020，18（1）：167 autophagy enhancer protein RUBCNL expression through
［30］DUAN R，ZHAI Y，WANG Q，et al. LINC01764 promotes histone H3 lysine 18 lactylation（H3K18la）in colorectal
colorectal cancer cells proliferation，metastasis，and 5⁃flu⁃ cancer［J］. Autophagy，2024，20（1）：114-130
orouracil resistance by regulating glucose and glutamine ［43］PASSARO A，BRAHMER J，ANTONIA S，et al. Manag⁃
metabolism via promoting c ⁃ MYC translation［J］. Med⁃ ing resistance to immune checkpoint inhibitors in lung
Comm，2024，5（11）：e70003 cancer：treatment and novel strategies［J］. JCO，2022，40
［31］XI Y，YUAN P，LI T，et al. hENT1 reverses chemoresis⁃ （6）：598-610
tance by regulating glycolysis in pancreatic cancer［J］. ［44］BAGCHI S，YUAN R，ENGLEMAN E G. Immune check⁃
Cancer Lett，2020，479：112-122 point inhibitors for the treatment of cancer：clinical im⁃
［32］LU C，QIAO P，SUN Y，et al. Positive regulation of pact and mechanisms of response and resistance［J］. Annu
PFKFB3 by PIM2 promotes glycolysis and paclitaxel re⁃ Rev Pathol Mech Dis，2021，16（1）：223-249
sistance in breast cancer［J］. Clin Transl Med，2021，11 ［45］DANESHMANDI S，WEGIEL B，SETH P. Blockade of
（4）：e400 lactate dehydrogenase⁃A（LDH⁃A）improves efficacy of anti
［33］XU M，CHEN S，YANG W，et al. FGFR4 links glucose ⁃programmed cell death⁃1（PD⁃1）therapy in melanoma［J］.
metabolism and chemotherapy resistance in breast can⁃ Cancers（Basel），2019，11（4）：450
cer［J］. Cell Physiol Biochem，2018，47（1）：151-160 ［46］QIAO T，XIONG Y，FENG Y，et al. Inhibition of LDH⁃A
［34］ZHAO M，ZHANG Y，LI L，et al. KHDRBS3 accelerates by oxamate enhances the efficacy of anti⁃PD⁃1 treatment
glycolysis and promotes malignancy of hepatocellular car⁃ in an NSCLC humanized mouse model［J］. Front Oncol，
cinoma via upregulating 14 ⁃ 3 ⁃ 3ζ［J］. Cancer Cell Int， 2021，11：632364
2023，23（1）：244 ［47］CAPPELLESSO F，ORBAN M P，SHIRGAONKAR N，et
［35］YOU Q，WANG J，YU Y，et al. The histone deacetylase al. Targeting the bicarbonate transporter SLC4A4 over⁃
SIRT6 promotes glycolysis through the HIF⁃1α/HK2 sig⁃ comes immunosuppression and immunotherapy resistance
naling axis and induces erlotinib resistance in non⁃small in pancreatic cancer［J］. Nat Cancer，2022，3（12）：1464-
cell lung cancer［J］. Apoptosis，2022，27（11⁃12）：883- 1483
898 ［48］CHEN T，XU Z G，LUO J，et al. NSUN2 is a glucose sen⁃
［36］ZHANG C，ZHOU W，XU H，et al. Cancer⁃associated fi⁃ sor suppressing cGAS/STING to maintain tumorigenesis
broblasts promote EGFR⁃TKI resistance via the CTHRC1/ and immunotherapy resistance［J］. Cell Metabolism，
glycolysis/H3K18la positive feedback loop［J］. Oncogene， 2023，35（10）：1782-1798
2025，44（19）：1400-1414 ［49］YU T，LIU Z，TAO Q，et al. Targeting tumor ⁃ intrinsic
［37］ZHANG T，PAN Z，GAO J，et al. Branched⁃chain amino SLC16A3 to enhance anti ⁃ PD ⁃ 1 efficacy via tumor im⁃
acid transaminase 1 confers EGFR⁃TKI resistance through mune microenvironment reprogramming［J］. Cancer Lett，
epigenetic glycolytic activation［J］. Sig Transduct Target 2024，589：216824
Ther，2024，9（1）：216 ［50］XU W，ZHOU B，WANG P，et al. N6 ⁃ methyladenosine
［38］DI S C，CHEN W J，YANG W，et al. DEPDC1 as a meta⁃ modification of 3’tRF⁃AlaAGC impairs PD⁃1 blockade ef⁃
bolic target regulates glycolysis in renal cell carcinoma ficacy by promoting lactic acid accumulation in the tumor
through AKT/mTOR/HIF1α pathway［J］. Cell Death Dis， microenvironment of gastric carcinoma［J］. Drug Resis⁃
2024，15（7）：533 tance Updates，2025，79：101197
［39］SWAIN S M，SHASTRY M，HAMILTON E. Targeting ［51］ZHANG P，YANG Y，QIAN K，et al. A novel tumor sup⁃
HER2⁃positive breast cancer：advances and future direc⁃ pressor ZBTB1 regulates tamoxifen resistance and aero⁃
tions［J］. Nat Rev Drug Discov，2023，22（2）：101-126 bic glycolysis through suppressing HER2 expression in